Election of employee representatives to the Board of Directors

05.03.25 13:51 Uhr

Werte in diesem Artikel
Aktien

53,86 EUR 0,06 EUR 0,11%

The employees  have conducted the election of employee representatives to the Board of Directors of Novonesis (Novozymes A/S).

Wer­bung

The following employee representatives (in alphabetical order after surname) were elected for the next four years:

  • Robert Nøddeskov Jensen, Senior Operator - newly elected
  • Lars Bo Køppler, Technician - newly elected
  • Preben Nielsen, Science Manager – re-elected
  • Frederikke Rose Spenner, Production Engineer - newly elected

As alternates to the employee representatives to the Board of Directors, the employees elected Mikael Barfred, Heidi Gelt and Ida Carlsen Virklund (listed in alphabetical order after surname).

Wer­bung

As re-elected, Preben Nielsen will continue in the Board of Directors, and the newly elected employee representatives will join the Board of Directors following the Annual General Meeting of Novonesis on April 3, 2025. At the same event, the term of election for the former employee representatives, Lena Bech Holskov, Anders Hentze Knudsen, and Jens Øbro will end.

The term of Board Observer Kim Ib Sørensen will also end following the Annual General Meeting of Novonesis on April 3, 2025.

Wer­bung

Attachment


Ausgewählte Hebelprodukte auf Novozymes A-S (B)

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Novozymes A-S (B)

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Novozymes A-S (B)

Wer­bung

Analysen zu Novozymes A-S (B)

DatumRatingAnalyst
17.10.2012Novozymes holdDeutsche Bank AG
03.09.2012Novozymes buyING
28.08.2012Novozymes overweightMorgan Stanley
09.08.2012Novozymes overweightMorgan Stanley
22.06.2012Novozymes overweightMorgan Stanley
DatumRatingAnalyst
03.09.2012Novozymes buyING
28.08.2012Novozymes overweightMorgan Stanley
09.08.2012Novozymes overweightMorgan Stanley
22.06.2012Novozymes overweightMorgan Stanley
17.11.2011Novozymes overweightMorgan Stanley
DatumRatingAnalyst
17.10.2012Novozymes holdDeutsche Bank AG
15.10.2010Novozymes holdVontobel Research
13.08.2010Novozymes holdVontobel Research
DatumRatingAnalyst
05.05.2005Novozymes: Sector UnderperformVontobel

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Novozymes A-S (B) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"